Key facts
- Capitainer’s last known valuation is $37.3M (Feb 2024).
- It has raised $24.0M; the latest was Angel (individual) ($3.5M) in Jun 2025.
- Notable investors include Nolsterby Invest, EASME - EU Executive Agency for SMEs, EIT Health, Mathias Uhlén, Network Society Ventures — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Capitainer
- ·The full record, as it builds
Funding rounds
No funding rounds for Capitainer are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Capitainer
Developer of volumetric microsampling devices designed to enable laboratory-quality blood collection through capillary self-sampling. The company offers technology that allows precise at-home blood sample collection and convenient return by mail, enabling patients and healthcare providers to access remote diagnostic testing with reduced need for in-person visits.
- Sector
- Healthcare
- HQ
- Solna, Sweden
- Founded
- 2016
- Employees
- 31
- Website
- capitainer.com/
- Ownership
- Privately Held (backing)
Capitainer doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Capitainer shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Capitainer in its N-PORT filings yet. We sweep new filings monthly.